Paper24709221
Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
Li C and 8 others. Int J Pharm, 2014. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous? Papers, record 24709221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24709221
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Cross-Linking Reagents | Major topic |
| Drug Carriers | Major topic |
| Paclitaxel | Major topic |
| Prostatic Neoplasms | Major topic |
| Albumin-Bound Paclitaxel | |
| Albumins | |
| Animals | |
| Cell Line, Tumor | |
| Chemistry, Pharmaceutical | |
| Drug Stability | |
| Injections, Intravenous | |
| Male | |
| Mice | |
| Nanoparticles | |
| Nanotechnology | |
| Permeability | |
| Rats, Wistar | |
| Solubility | |
| Technology, Pharmaceutical | |
| Tissue Distribution |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42198250 | Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198250 | PubMed |
| 40870994 | Enhancing Parenteral Nutrition via Supplementation with Antioxidant Lutein in Human Serum Albumin-Based Nanosuspension. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40870994 | PubMed |
| 40725126 | Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725126 | PubMed |
| 40162333 | Targeting Delivery of Dexamethasone to Inflamed Joints by Albumin-Binding Peptide Modified Liposomes for Rheumatoid Arthritis Therapy. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40162333 | PubMed |
| 39950848 | Periodate-Mediated Cross-Linking for the Preparation of Catechol Conjugated Albumin Nanoparticles Used for in Vitro Drug Delivery. | ACS Appl Bio Mater | 2025 | https://conductscience.org/library/papers/39950848 | PubMed |
| 39766308 | Core-Shell PLGA Nanoparticles: In Vitro Evaluation of System Integrity. | Biomolecules | 2024 | https://conductscience.org/library/papers/39766308 | PubMed |
| 39758671 | A Nanotheranostic Agent for Synergistic Antitumor Chemo/Phototherapy Prepared by Paclitaxel-Induced Self-Assembly of PEGylated Human Serum Albumin with Prolonged Circulation. | ACS Omega | 2024 | https://conductscience.org/library/papers/39758671 | PubMed |
| 39638910 | A Novel Self-Assembled Paclitaxel Nanodispersion Facilitates Rapid In-Vitro/In-Vivo Dissociation and Protein Binding. | AAPS PharmSciTech | 2024 | https://conductscience.org/library/papers/39638910 | PubMed |
| 38918979 | Folate-Modified Curcumin-Loaded Nanoparticles for Overcoming Delivery Challenges in Cancer Treatment: A Narrative Review. | Curr Pharm Biotechnol | 2025 | https://conductscience.org/library/papers/38918979 | PubMed |
| 38323081 | GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38323081 | PubMed |
| 37204680 | Medium-chain triglyceride-stabilized docetaxel-loaded HSA nanoparticles effectively inhibited metastatic non-small cell lung cancer. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/37204680 | PubMed |
| 36839841 | Intravital Microscopy Reveals Endothelial Transcytosis Contributing to Significant Tumor Accumulation of Albumin Nanoparticles. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839841 | PubMed |
| 35456562 | Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456562 | PubMed |
| 35059018 | Polymer-based nanoparticles: fabrication to applications-the many faces of DC8,9PC and albumin. | Biophys Rev | 2021 | https://conductscience.org/library/papers/35059018 | PubMed |
| 34202848 | Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/34202848 | PubMed |
| 33396604 | Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33396604 | PubMed |
| 31195727 | Albumin Nanovectors in Cancer Therapy and Imaging. | Biomolecules | 2019 | https://conductscience.org/library/papers/31195727 | PubMed |
| 29946256 | Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29946256 | PubMed |
| 29872625 | Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma. | Acta Pharm Sin B | 2018 | https://conductscience.org/library/papers/29872625 | PubMed |
| 28599410 | Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells. | Oncol Lett | 2017 | https://conductscience.org/library/papers/28599410 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| SPARC | 6678 | PubTator's text mining | https://conductscience.org/library/genes/6678 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24709221
GET https://conductscience.org/api/papers/v1/24709221/cited_by?page=2